NPDB Reporting Under DHA-PM 6025.13, Volume 3 — What Military Healthcare Providers Must Understand
One of the most consequential — and least understood — aspects of military healthcare provider defense is how the National Practitioner Data Bank reporting requirement under DHA-PM 6025.13, Volume 3 works in practice. A summary suspension triggers a mandatory NPDB report after 30 days. Reinstatement two years later updates the record — but does not erase it. The report remains, visible to every credentialing entity, for the duration of a provider's career.
Once a summary suspension reaches 30 days without resolution, a mandatory NPDB report is filed. That clock cannot be stopped after the fact. What can be controlled is the quality of the peer review hearing defense — which determines both whether the provider is reinstated and how the NPDB entry is ultimately characterized. Contact Korody Law immediately for a free consultation.
On This Page
- What the NPDB Is and Why It Matters for Military Providers
- The DHA-PM 6025.13, Volume 3 Reporting Framework
- The 30-Day Rule — When Reporting Becomes Mandatory
- The Full NPDB Report Lifecycle — From Suspension to Final Entry
- An Illustrative Case — What the Full Process Looks Like
- Reinstatement Reality — What Full Reinstatement Does and Does Not Do
- Why Defense at the Hearing Stage Is the Most Important Intervention
- Provider Rights Under the NPDB Regulations
- Frequently Asked Questions
What the NPDB Is — and Why It Matters for Military Providers
The National Practitioner Data Bank (NPDB) is a federal information clearinghouse administered by the Health Resources and Services Administration (HRSA) under the U.S. Department of Health and Human Services. Established by Title IV of the Health Care Quality Improvement Act of 1986, it collects and releases information related to the malpractice payment history and professional competence and conduct of physicians, dentists, and other licensed healthcare practitioners nationwide.
Its scope has expanded significantly since its creation. Section 1921 of the Social Security Act broadened NPDB authority to capture adverse actions by state licensing authorities, peer review organizations, and private accreditation organizations. Section 1128E — added by HIPAA in 1996 and modified by the Affordable Care Act — brought federal agency adverse actions into the NPDB, including actions taken by the Defense Health Agency against military healthcare providers.
The NPDB is queried by every hospital, health system, managed care organization, insurance company, and state licensing board in the country when credentialing a provider. An NPDB entry does not stay at the military treatment facility where it was generated — it follows the provider into every civilian credentialing application, every hospital staff application, and every employment decision for the rest of their career. This is why a summary suspension at a military MTF has consequences that extend far beyond the military career itself.
The DHA-PM 6025.13, Volume 3 Reporting Framework
Defense Health Agency Policy Manual 6025.13, Volume 3 — "Clinical Quality Management in the Military Health System: Healthcare Risk Management," effective August 29, 2019 — is the governing document for NPDB reporting by military treatment facilities. It implements the requirements of DoD Instruction 6025.13 within the DHA framework and specifies when, how, and in what form MTFs must report adverse privileging actions to the NPDB.
Under this framework, reportable adverse privileging actions fall under Title IV of the Health Care Quality Improvement Act. The Defense Health Agency — not the individual MTF — is the reporting entity in the NPDB system for all military providers. Reports are submitted through DHA headquarters and are associated with the specific MTF where the action occurred.
What Must Be Reported
- Summary or emergency suspension of clinical privileges lasting more than 30 days
- Restriction, reduction, or revocation of clinical privileges following formal peer review
- Resignation or voluntary relinquishment of privileges while under investigation or while charges are pending
- Any final adverse clinical privilege action accepted by the Privileging Authority
What Is Not Reported
- Summary suspensions resolved within 30 days — no report is made if fully resolved before the threshold
- Reinstatement with monitoring only (FPPE or M&E) — not a reportable adverse clinical privilege action under DHA-PM 6025.13
- Voluntary changes in scope of practice not initiated in a quality or conduct investigation context
- Temporary privilege limitations imposed during routine FPPE for new privileges
The Two Report Types
- Initial Report: Filed when the 30-day threshold is crossed, documenting the suspension and noting due process proceedings are ongoing
- Revision Report: Filed after due process concludes, updating the initial report with the final outcome — reinstatement, restriction, reduction, or revocation
- Both reports remain in the NPDB permanently — the initial report is not deleted when the revision is filed, it is updated and linked
The 30-Day Rule — When Reporting Becomes Mandatory
The 30-day clock starts when the summary suspension begins. It does not pause for administrative delays, pending investigations, or scheduling backlogs. When it expires, the NPDB report is filed regardless of where the due process proceedings stand.
DHA-PM 6025.13, Volume 3 requires that a report be submitted to the NPDB when a provider's clinical privileges are placed in summary suspension and that suspension is not resolved within 30 days. The clock begins on the effective date of the suspension — not when the provider receives written notice, not when the QAI is complete, and not when the hearing is scheduled.
Before day 30, a defense that achieves early reinstatement avoids the NPDB report entirely. After day 30, the report is mandatory — and the focus shifts from preventing the report to managing what that report ultimately says when the proceedings conclude.
Why Reinstatement Within 30 Days Is Extremely Rare
While the 30-day threshold theoretically creates an incentive for rapid due process, full reinstatement within 30 days almost never occurs. The quality assurance investigation alone typically requires weeks to complete. The QAI must be provided to the provider with time to respond. A formal peer review hearing must be scheduled, conducted, and deliberated. The Privileging Authority must issue a determination.
From the provider's perspective, the 30-day reinstatement window is rarely the achievable primary goal. The primary goal is the quality and completeness of the defense at the peer review hearing — because that defense determines the ultimate NPDB entry.
What the Initial NPDB Report Contains
The initial report filed at day 30 contains the provider's full identifying information, the nature of the adverse action, the basis for the action, the effective date, and a description of the acts or omissions or reasons for the action — as described by the reporting entity.
The report specifically notes the suspension is pending completion of due process and will be revised to reflect the final outcome. This language is visible to every querying entity — signaling an active adverse action before any hearing has been held and before any finding of wrongdoing has been made.
Every hospital, employer, and licensing authority that queries the NPDB while proceedings are pending sees a report indicating an active suspension with no resolution. For a provider seeking concurrent civilian employment, credentialing, or license renewal during the pendency of proceedings, that initial report has immediate real-world consequences — even before any hearing.
The Full NPDB Report Lifecycle — From Suspension to Final Entry
Understanding the complete lifecycle of an NPDB report — from initial summary suspension through final revision — is essential to understanding where the most impactful defense interventions occur and what is ultimately at stake in each phase.
Stage 1: Summary Suspension
The MTF Privileging Authority issues a summary suspension, removing the provider from clinical duties immediately. The 30-day NPDB clock begins. This is the most critical early intervention point — defense counsel should engage before the first statement is made, before the QAI begins interviewing witnesses, and before the official record of the proceeding is established.
Stage 2: Quality Assurance Investigation
A QAI officer reviews clinical records, incident circumstances, and relevant witness accounts. The QAI report is the foundational document in the adverse action proceeding. The provider receives the QAI and has the right to submit a written response before it is forwarded to the Privileging Authority. This QAI response is among the most consequential submissions in the entire process — and is almost always prepared without adequate legal guidance when counsel was not retained early.
Stage 3: Initial NPDB Report at Day 30
If the suspension is not resolved within 30 days, DHA files the initial NPDB report. It documents the suspension, the basis for action, and notes that due process proceedings are pending. This report is immediately visible to any querying entity and signals an active adverse action even before a hearing or finding.
Stage 4: Formal Peer Review Hearing
The provider appears before a formal Peer Review Panel — a transcribed, evidentiary proceeding under DHA-PM 6025.13, Volume 3. The panel hears evidence, examines witnesses, and makes written findings and a recommendation to the Privileging Authority. The preponderance standard applies. The quality of the defense at this hearing determines the panel's recommendation — and ultimately the content of the NPDB revision report.
Stage 5: Privileging Authority Decision
The Privileging Authority reviews the panel's recommendation and issues a final decision: reinstatement, reinstatement with monitoring, restriction, reduction, or revocation. If adverse, the provider has the right to appeal to the Director of DHA. The final decision determines what is reported in the NPDB revision.
Stage 6: NPDB Revision Report
After proceedings conclude, DHA files a revision to the initial NPDB report reflecting the final outcome. Both the initial report and the revision remain in the database, linked together, permanently visible to querying entities. Reinstatement is reflected favorably — but the full report history remains accessible to every credentialing entity that queries the record.
An Illustrative Case — What the Full Process Looks Like in Practice
The following is an anonymized illustration of how the DHA-PM 6025.13, Volume 3 NPDB reporting process unfolds in a real case — from initial summary suspension through final reinstatement. All identifying information has been removed. The case is provided to illustrate how the process works and what the NPDB record ultimately reflects.
This case illustrates features common to DHA adverse privileging proceedings. The suspension was based on professional misconduct — not a patient care quality event. The process took two years from suspension to final reinstatement in a case that did not even involve a peer review hearing. Throughout that period, the initial NPDB report was visible to any credentialing entity that queried the database. The revision filed after reinstatement updates the record to reflect the favorable outcome — but both the initial report and the revision remain permanently accessible.
The NPDB Timeline
-
1August 2023
Summary Suspension Issued
Clinical privileges placed in summary suspension for professional misconduct concerns. Provider removed from clinical duties immediately. The 30-day NPDB clock begins. This is the moment where early legal intervention is most critical — before any statement is made, before the QAI collects evidence, and before the official record accumulates.
-
2September 2023 — Day 30+
Initial NPDB Report Filed
The suspension was not resolved within 30 days. DHA filed the initial NPDB report documenting the suspension, its basis, and noting that due process proceedings were ongoing. From this date forward, any hospital, employer, or licensing body querying the provider's NPDB record saw the active suspension report.
-
3September 2023 – August 2025
Investigation and Due Process
Command investigation completed and disposition reached. QAI followed and found no nexus between the misconduct and patient safety nor the integrity of the military health system. The redacted QAI was provided to the provider with opportunity to respond. The Privileging Authority issued a final determination reinstating privileges based on the QAI and provider submission. This process — from suspension to final decision — spanned approximately 24 months. Throughout, the NPDB record showed an active, unresolved adverse action.
-
4August 2025
Full Reinstatement of Clinical Privileges
The Privileging Authority reinstated the provider's clinical privileges in full — the most favorable possible outcome following a summary suspension. The reinstatement was complete, not conditional or monitored.
-
5September 2025
NPDB Revision Report Filed
DHA filed the revision to the initial report reflecting the final outcome: clinical privileges restored or reinstated, complete. The revision is linked to the initial report and is visible alongside it. The NPDB record now shows both the initial summary suspension and the full reinstatement — permanently.
Reinstatement Reality — What Full Reinstatement Does and Does Not Do
Full reinstatement is the best possible outcome of the due process proceedings. It is not a clean slate. The NPDB record of the summary suspension does not disappear — it is updated to show the favorable final outcome, but both entries remain permanently visible to every credentialing entity.
Many providers assume that if the peer review process concludes with full reinstatement, the NPDB report disappears. This assumption is incorrect and has significant consequences for how providers plan their post-military careers. Full reinstatement updates the NPDB record; it does not erase it.
What Full Reinstatement Achieves
- Updates the initial NPDB report with a revision reflecting "Clinical Privileges Restored or Reinstated, Complete"
- Removes the "unresolved adverse action" characterization that querying entities see during the pendency of proceedings
- Provides factual basis to explain the NPDB entry in future credentialing — the record shows suspension followed by full reinstatement, not sanction
- Preserves eligibility for civilian hospital credentialing, state licensing, and employment that restriction, reduction, or revocation would have foreclosed
- Supports the provider's right to submit a subject statement that appears alongside the NPDB entry in all future queries
What Full Reinstatement Does Not Do
- Does not remove the initial summary suspension report from the NPDB — both initial and revision entries remain permanently accessible
- Does not prevent civilian credentialing entities from seeing that a summary suspension occurred and asking about it
- Does not undo the period — potentially months or years — during which the unresolved suspension was visible to querying entities
- Does not automatically resolve any parallel state licensing board notifications generated during the suspension period
- Does not eliminate the obligation to disclose the NPDB entry in credentialing applications that ask about adverse privilege actions — even where the final outcome was reinstatement
The practical lesson: A provider who achieves full reinstatement after extended due process proceedings is in a fundamentally better position than one who receives even a minor restriction. But neither is in the position of a provider who resolved the matter before day 30. The NPDB entry is a permanent feature of the career landscape — which is why the defense that produces the best final entry matters so profoundly.
Why Defense at the Hearing Stage Is the Most Important Intervention
Given that the 30-day NPDB report is virtually certain once a summary suspension is issued, the most critical defense objective is not preventing the initial report — it is ensuring that the revision report reflects the best possible final outcome. If the initial action by the Privileging Authority is to propose an adverse action, the formal peer review hearing becomes the most critical stage of due process and has the most impact on the final NPDB report. The quality of the hearing defense is the quality of the NPDB revision.
What the Hearing Determines
- Reinstatement vs. sanction: The panel's recommendation determines which outcome is reported to the NPDB. Full reinstatement, reinstatement with monitoring (not NPDB-reportable), restriction, reduction, or revocation all produce fundamentally different NPDB revision entries with profoundly different career consequences
- Characterization of the basis: How the panel's findings describe the reason for the adverse action affects how the NPDB entry reads to future credentialing entities — and whether state licensing boards take parallel action
- The appeal record: The hearing record is the foundation for any DHA appeal if the Privileging Authority's decision is adverse — a well-built hearing record supports a meaningful appeal opportunity
What Effective Defense Requires
- Retention of defense counsel before the QAI is complete and before any statement is made
- A comprehensive, strategically framed response to the QAI — often the single most consequential written submission in the entire proceeding
- Full preparation for the peer review hearing — voir dire, opening statement, cross-examination, expert evidence, and closing argument
- Simultaneous management of any parallel UCMJ, ADSEP, or security clearance proceedings triggered by the same conduct
- Post-hearing NPDB strategy — subject statement preparation and dispute process evaluation where appropriate
Attorney Patrick Korody has defended military healthcare providers in DHA adverse privileging proceedings since 2009 — representing uniformed officers, civilian employees, and contractors at MTFs across the Army, Navy, and Air Force, including facilities worldwide. He has represented providers through the complete DHA-PM 6025.13 process, from summary suspension through peer review hearing, Privileging Authority decision, DHA appeal, and NPDB post-decision strategy.
The biggest mistake providers make after a summary suspension is attempting to informally resolve the matter through conversation with the MTF — without counsel, without understanding what is being recorded, and without appreciating how the statements made in those conversations become the QAI's evidence. Early legal engagement is not a luxury; it is the foundation of every successful defense in these proceedings.
Provider Rights Under the NPDB Regulations
The NPDB regulations at 45 CFR Part 60 provide providers who are the subjects of NPDB reports with specific rights that are independent of the DHA due process proceedings. These rights apply whether or not the provider prevails in the underlying adverse privileging action, and they are available throughout the life of the report.
Self-Query Right
Any provider can query their own NPDB record at any time through the NPDB self-query system. Self-query responses contain the complete content of all reports on file — including unabridged report text, all revision reports, and any subject statements already on file. Providers should query their own records periodically, and specifically after any adverse action proceeding concludes, to verify the accuracy of the NPDB entry and confirm that revision reports have been properly filed.
Subject Statement Right
A provider who is the subject of an NPDB report has the right to submit a written subject statement that appears alongside the report entry whenever it is queried by a third party. A well-crafted subject statement provides context, explains the circumstances of the adverse action and its resolution, and ensures that any entity querying the record receives the provider's account alongside the DHA's. Subject statement preparation should be part of every military provider defense strategy following an adverse privileging action.
Dispute Process
Providers who believe an NPDB report contains factual inaccuracies — information that is incorrect, incomplete, or that does not comply with NPDB reporting requirements — have the right to initiate a formal dispute through the NPDB's dispute resolution process. The dispute is referred to the Secretary of HHS for review. While the dispute is pending, the report remains visible and is flagged as disputed. Successful disputes result in correction or removal of inaccurate information.
Summarily Suspended at a Military MTF? Call Korody Law First.
The 30-day NPDB deadline cannot be reversed. But the quality of the peer review hearing defense — and the NPDB revision it produces — can still determine everything. Free consultation for summarily suspended providers.
Frequently Asked Questions
-
No. Full reinstatement updates the NPDB record with a revision report reflecting the favorable outcome — "Clinical Privileges Restored or Reinstated, Complete" — but it does not delete the initial summary suspension report. Both the initial report and the revision remain permanently in the database, linked together and visible to any entity that queries the record. Future credentialing applications that ask about adverse privilege actions will still need to address the NPDB entry, even when the final outcome was full reinstatement. The subject statement right and the ability to provide credentialing context are important tools for managing the record going forward.
-
The initial NPDB report is filed when a summary suspension reaches 30 days without resolution. It documents the suspension and notes that due process proceedings are pending. The revision report is filed after due process concludes and reflects the final outcome — reinstatement, restriction, reduction, or revocation. Both reports remain in the database and are visible when the record is queried. They are linked together so querying entities can see both the initial action and the final outcome. The revision report is labeled as a "Revision" and identifies the related initial report by document control number.
-
Yes. The initial report includes a description of the acts or omissions or other reasons for the adverse action as reported by DHA. This description identifies the general category of concern — clinical competence, professional misconduct, impairment, or other basis — and may include specific narrative language. This description is visible to every querying entity, which is why how the basis for the adverse action is characterized in the DHA proceedings matters significantly. A carefully defended proceeding can sometimes influence how the basis is described in ways that are less prejudicial in subsequent credentialing contexts.
-
Leaving the military while under summary suspension does not stop the DHA adverse privileging process or the NPDB reporting obligations. DHA can complete the adverse privileging proceeding and file both an initial and revision NPDB report even after the provider has separated from service. Providers who leave while under suspension must immediately request in writing that due process procedures continue — failure to do so does not prevent the adverse action from being completed and reported, but it eliminates the provider's ability to participate in the proceeding that determines what their NPDB record ultimately shows. Departing without properly invoking continuation rights is one of the most consequential mistakes a provider can make.
-
Yes — if the report contains factual inaccuracies or does not comply with NPDB reporting requirements. The NPDB dispute process allows the subject of a report to seek review by the Secretary of HHS. The dispute must be based on specific factual inaccuracies or non-compliance with reporting requirements — it is not a mechanism for re-litigating the underlying adverse privileging action. While a dispute is pending, the report remains visible and is flagged as disputed. A subject statement can be submitted independently of a dispute and is available regardless of whether the provider believes the report is factually inaccurate.
Related Practice Areas
Summary Suspension. NPDB Report. Career at Stake. Korody Law.
Patrick Korody has defended military healthcare providers in DHA-PM 6025.13 adverse privileging proceedings since 2009 — from summary suspension through peer review hearing, Privileging Authority decision, and NPDB revision. Contact us for a free and confidential consultation.
Korody Law, P.A. · 630 West Adams Street, Suite 208, Jacksonville, FL 32204 · Military Healthcare Provider Defense Since 2009